The long-term risk for myocardial infarction or stroke after proton pump inhibitor therapy (2008-2018),Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The long-term risk for myocardial infarction or stroke after proton pump inhibitor therapy (2008-2018)
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-09-03 , DOI: 10.1111/apt.16565
Michael Nolde _{1,

2} , Nayeon Ahn _{1,

2} , Tobias Dreischulte ₃ , Ina-Maria Rückert-Eheberg _{1,

2,

4} , Florian Güntner ₅ , Alexander Günter ₅ , Roman Gerlach ₆ , Martin Tauscher ₆ , Ute Amann ₇ , Jakob Linseisen _{1,

2,

7} , Christa Meisinger ₂ , Sebastian-Edgar Baumeister ₈

Affiliation

Proton pump inhibitors (PPIs) are well tolerated in the short term but have recently been associated with increased long-term cardiovascular risk in observational studies.

中文翻译：